There's a pretty good chance that if you use store-brand OTC consumer health products, you have a Perrigo (NYSE: PRGO )
product in your bathroom right now. Perrigo hasn't completely eschewed
the prescription-based generic drug business that build companies like Teva (NYSE: TEVA )
, but it has focused a great deal of its time and energy on ruling the
store-brand OTC market. That business now offers pretty solid cash flow
and returns, with plenty of growth opportunity in areas like diabetes
and pet care. Perrigo doesn't exactly carry a "store-brand" multiple
today, but these shares could still offer some upside as the company
looks forward to further OTC launches, additional M&A, and growth in
the nutrition and overseas markets.
Read more here:
Can Perrigo Company PLC Continue Its Bull Run?
No comments:
Post a Comment